Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,852 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Implementation of Adenovirus-Mediated Pulmonary Expression of Human ACE2 in HLA Transgenic Mice Enables Establishment of a COVID-19 Murine Model for Assessment of Immune Responses to SARS-CoV-2 Infection.
Chitlaru T, Bar-Haim E, Bar-On L, Rotem S, Cohen H, Elia U, Gur D, Aftalion M, Alkalay R, Makdasi E, Evgy Y, Falach R, Israeli M, Bercovich-Kinori A, Achdout H, Yahalom-Ronen Y, Rosenfeld R, Cohen O. Chitlaru T, et al. Among authors: cohen h, cohen o. Pathogens. 2021 Jul 26;10(8):940. doi: 10.3390/pathogens10080940. Pathogens. 2021. PMID: 34451403 Free PMC article.
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs.
Madar-Balakirski N, Rosner A, Melamed S, Politi B, Steiner M, Tamir H, Yahalom-Ronen Y, Bar-David E, Ben-Shmuel A, Sittner A, Glinert I, Weiss S, Bar-Haim E, Cohen H, Elia U, Achdout H, Erez N, Rotem S, Lazar S, Nyska A, Yitzhaki S, Beth-Din A, Levy H, Paran N, Israely T, Marcus H. Madar-Balakirski N, et al. Among authors: cohen h. Arch Toxicol. 2022 Mar;96(3):859-875. doi: 10.1007/s00204-021-03214-w. Epub 2022 Jan 15. Arch Toxicol. 2022. PMID: 35032184 Free PMC article.
Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.
Milo R, Staun-Ram E, Karussis D, Karni A, Hellmann MA, Bar-Haim E, Miller A; Israeli Neuroimmunology Study Group on COVID-19 Vaccination in Multiple Sclerosis. Milo R, et al. Front Immunol. 2022 Apr 1;13:868915. doi: 10.3389/fimmu.2022.868915. eCollection 2022. Front Immunol. 2022. PMID: 35432335 Free PMC article.
Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice.
Bar-On L, Aftalion M, Makdasi E, Gur D, Alcalay R, Cohen H, Beth-Din A, Rosenfeld R, Achdout H, Bar-Haim E, Falach R, Chitlaru T, Cohen O. Bar-On L, et al. Among authors: cohen h, cohen o. Vaccines (Basel). 2022 Apr 14;10(4):613. doi: 10.3390/vaccines10040613. Vaccines (Basel). 2022. PMID: 35455362 Free PMC article.
3,852 results